Literature DB >> 19733555

Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease.

Sarah Aldred1, Stuart Bennett, Patrizia Mecocci.   

Abstract

OBJECTIVES: The two most common forms of dementia are Alzheimer's disease (AD), and vascular dementia (VaD). In the overlap of biochemical processes which have been identified in AD and VaD, oxidative stress is believed to contribute to the numerous pathologies of both dementias. DESIGN AND METHODS: This study assessed oxidative damage in total plasma proteins, and isolated LDL in AD patients and age matched controls, in addition total antioxidant capacity (TAC) was measured.
RESULTS: Significantly higher LDL protein carbonylation was observed in AD compared to age-matched controls (AD: 4.17+/-0.73 vs. control: 3.85+/-0.86 nmol/mg LDL; p=0.05, 2-tailed Mann-Whitney), in addition to reduced TAC (AD: 924.708+/-174.429 vs. control: 1078.536+/-252.633 microM; p=0.001, 2-tailed Mann-Whitney). No differences were seen in total plasma protein carbonyl content (AD: 3.88+/-0.31 vs. control: 3.98+/-0.48 nmol/mg protein).
CONCLUSION: The results further support the view that oxidation events in AD may be specific in nature, and represent functional changes to proteins, rather than random global events. (c) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733555     DOI: 10.1016/j.clinbiochem.2009.08.021

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  14 in total

1.  DNA-PK and P38 MAPK: A Kinase Collusion in Alzheimer's Disease?

Authors:  Jyotshna Kanungo
Journal:  Brain Disord Ther       Date:  2017-05-01

Review 2.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

3.  Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment.

Authors:  Claudius Mueller; Matthew Schrag; Andrew Crofton; Jens Stolte; Martina U Muckenthaler; Shino Magaki; Wolff Kirsch
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  The effect of citalopram treatment on amyloid-β precursor protein processing and oxidative stress in human hNSC-derived neurons.

Authors:  R J Elsworthy; J A Crowe; M C King; C Dunleavy; E Fisher; A Ludlam; H R Parri; E J Hill; S Aldred
Journal:  Transl Psychiatry       Date:  2022-07-18       Impact factor: 7.989

5.  DNA-PK Deficiency in Alzheimer's Disease.

Authors:  Jyotshna Kanungo
Journal:  J Neurol Neuromedicine       Date:  2016-09

6.  Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease.

Authors:  Ameneh Moslemnezhad; Soleiman Mahjoub; Mehdi Moghadasi
Journal:  Caspian J Intern Med       Date:  2016

7.  Lipid and protein oxidation in female patients with chronic fatigue syndrome.

Authors:  Slavica Tomic; Snezana Brkic; Daniela Maric; Aleksandra Novakov Mikic
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

Review 8.  Blood markers of oxidative stress in Alzheimer's disease.

Authors:  Alice Skoumalová; Jakub Hort
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

Review 9.  The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic review.

Authors:  Ya-Ting Chang; Wen-Neng Chang; Nai-Wen Tsai; Chih-Cheng Huang; Chia-Te Kung; Yu-Jih Su; Wei-Che Lin; Ben-Chung Cheng; Chih-Min Su; Yi-Fang Chiang; Cheng-Hsien Lu
Journal:  Biomed Res Int       Date:  2014-05-14       Impact factor: 3.411

10.  Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer's Disease Mice.

Authors:  Liming Shen; Youjiao Chen; Aochu Yang; Cheng Chen; Liping Liao; Shuiming Li; Ming Ying; Jing Tian; Qiong Liu; Jiazuan Ni
Journal:  Int J Mol Sci       Date:  2016-04-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.